Urgent.ly (NASDAQ: ULY) amends Schedule 14D-9; $5.50 cash offer, advisor fees disclosed
Rhea-AI Filing Summary
Urgent.ly Inc. filed Amendment No. 1 to its Schedule 14D-9 supplementing disclosures about the proposed cash acquisition by Medford Hawk, Inc./Agero at an Offer Price of $5.50 per share. The amendment describes additional advisor engagements, financing history, board actions and supplemental non‑public projections used in the company’s review.
The filing discloses advisor payments and fees, including $90,000 of retainers and a $350,000 success fee to Alchemy Advisors, and an estimated contingent fee to Pericles of $4,310,000. It summarizes an October 2025 Alternative Forecast (including an assumed cash infusion of over $40 million) and provides multi‑year projection line items for Total Revenue and EBITDA for 2025–2029.
Positive
- None.
Negative
- None.
Insights
Amendment clarifies process, advisor fees, and board deliberations around the $5.50 cash offer.
The supplemental disclosures detail the formation and role of a Transaction Committee, advisor engagements with Alchemy and Pericles, and the company’s financing interactions (MidCap ABL and 2L Term Loan amendments). The filing emphasizes that supplemental information is voluntary and not an admission of legal deficiency.
Key dependencies include lender consent dynamics and the absence of third‑party capital for the Alternative October 2025 Forecast; subsequent litigation risk from demand letters is acknowledged without guaranteed disclosure of future claims.
Pericles’ valuation inputs and alternative forecasts are disclosed but not relied upon as primary bases for the board’s decision.
Pericles used discounted cash flows (discount rates of 14.5%–16.5%), a median exit multiple of 10.3, and a terminal growth rate of 3.5% to derive a range of values. The company also provided an Alternative October 2025 Forecast assuming a > $40 million cash infusion and projected revenues and EBITDA through 2029.
These disclosures allow review of the valuation assumptions; actual reliance on these forecasts by the board and advisors is explicitly limited in the filing.
Key Figures
Key Terms
Transaction Committee regulatory
Alternative October 2025 Forecast financial
MidCap ABL financial
don’t ask, don’t waive legal
AI-generated analysis. How Rhea-AI works. Not financial advice.